Iterum Therapeutics plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ITRMF | 1952.HK | INVA | NIKI | RCE.AX | SPRO | |
|---|---|---|---|---|---|---|
| Market cap | 532 | 9.83B | 1.54B | 5.27M | 100.93M | 62.31M |
| P/E (TTM) | — | — | 5.0 | — | — | 7.6 |
| Forward P/E | — | 20.4 | 9.6 | — | 17.4 | -1.0 |
| Price/book | 0.0 | 1.3 | 1.4 | 0.1 | -5.7 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −100.00% | −44.53% | +14.81% | −87.43% | −19.28% | −55.23% |
| Today | 0.00% | +5.06% | +1.58% | −3.98% | −1.49% | +2.88% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All ITRMF news ›Sol-Gel Technologies (NASDAQ:SLGL) & Iterum Therapeutics (NASDAQ:ITRM) Head to Head Review
Iterum Therapeutics (NASDAQ:ITRM – Get Free Report) and Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of…
Financial Review: Arcutis Biotherapeutics (NASDAQ:ARQT) and Iterum Therapeutics (NASDAQ:ITRM)
Posted by Kim Johansen on Oct 6th, 2026 Iterum Therapeutics (NASDAQ:ITRM – Get Free Report) and Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- defenseworld.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.